m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance DOI Creative Commons
Tengfei Zhou, Shichao Li, Daimin Xiang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2020, Volume and Issue: 5(1)

Published: Dec. 26, 2020

Abstract Hepatocyte nuclear factor 3γ (HNF3γ) is a hepatocyte factor, but its role and clinical significance in hepatocellular carcinoma (HCC) remain unclear. Herein, we report that HNF3γ expression downregulated patient HCC inversely correlated with malignancy survival. Moreover, our data suggested the reduction could be mediated by METTL14-dependent m6A methylation of mRNA. was increased during hepatic differentiation decreased dedifferentiated cells. Interestingly, delivery promoted not only cells also liver CSCs, which led to suppression growth. Mechanistic analysis an HNF3γ-centered regulatory network includes essential differentiation-associated transcription factors functional molecules, synergistically facilitate cell differentiation. More importantly, enforced sensitized sorafenib-induced growth inhibition apoptosis through transactivation OATP1B1 OATP1B3 expression, are major membrane transporters for sorafenib uptake. Clinical investigation showed patient-derived xenografts high exhibited response patients levels benefited from therapy. Together, these results suggest plays may serve as therapeutic target predictor benefit patients.

Language: Английский

Hallmarks of Cancer: New Dimensions DOI Open Access
Douglas Hanahan

Cancer Discovery, Journal Year: 2022, Volume and Issue: 12(1), P. 31 - 46

Published: Jan. 1, 2022

The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity phenotypes and genotypes into provisional set underlying principles. As knowledge mechanisms has progressed, other facets disease have emerged as potential refinements. Herein, prospect raised that phenotypic plasticity disrupted differentiation discrete hallmark capability, nonmutational epigenetic reprogramming polymorphic microbiomes both constitute distinctive enabling characteristics facilitate acquisition capabilities. Additionally, senescent cells, varying origins, may be added to roster functionally important cell types in tumor microenvironment. SIGNIFICANCE: Cancer daunting breadth scope its diversity, spanning genetics, tissue biology, pathology, response therapy. Ever more powerful experimental computational tools technologies are providing an avalanche "big data" about myriad manifestations diseases encompasses. integrative concept embodied helping distill this increasingly logical science, new dimensions presented perspective add value endeavor, fully understand development malignant progression, apply medicine.

Language: Английский

Citations

3308

Targeting transcription factors in cancer — from undruggable to reality DOI
John H. Bushweller

Nature reviews. Cancer, Journal Year: 2019, Volume and Issue: 19(11), P. 611 - 624

Published: Sept. 11, 2019

Language: Английский

Citations

724

Cancer stemness, intratumoral heterogeneity, and immune response across cancers DOI Open Access
Alex Miranda, Phineas T. Hamilton, Allen W. Zhang

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2019, Volume and Issue: 116(18), P. 9020 - 9029

Published: April 17, 2019

Significance The exclusion of immune cells from the tumor microenvironment has been associated with poor prognosis in majority cancers. We report that when considering 21 solid cancer types, cell is widely presence a stem cell-like phenotype tumors (“stemness”). Stemness positively correlates higher intratumoral heterogeneity, possibly by protecting antigenic clones elimination system. activation stemness program appears to limit antitumor responses via cell-intrinsic silencing endogenous retrovirus expression, repression type I interferon signaling, and up-regulation immunosuppressive checkpoints. Our work suggests targeting will promote T infiltration render more responsive control.

Language: Английский

Citations

458

Metabolic signatures of cancer cells and stem cells DOI Open Access
Andrew M. Intlekofer, Lydia W.S. Finley

Nature Metabolism, Journal Year: 2019, Volume and Issue: 1(2), P. 177 - 188

Published: Feb. 11, 2019

Language: Английский

Citations

281

Meta-hallmarks of aging and cancer DOI Creative Commons
Carlos López-Otı́n, Federico Pietrocola, David Roiz‐Valle

et al.

Cell Metabolism, Journal Year: 2023, Volume and Issue: 35(1), P. 12 - 35

Published: Jan. 1, 2023

Language: Английский

Citations

274

Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages DOI Creative Commons
Degao Chen, Xiaomei Zhang, Zhongjun Li

et al.

Theranostics, Journal Year: 2020, Volume and Issue: 11(3), P. 1016 - 1030

Published: Nov. 6, 2020

Macrophages phagocytize pathogens to initiate innate immunity and products from the tumor microenvironment (TME) mediate immunity. The loss of tumor-associated macrophage (TAM)-mediated immune responses results in suppression. To reverse this disorder, regulatory mechanism TAMs TME needs be clarified. Immune molecules (cytokines chemokines) have been widely accepted as mutual mediators signal transduction past few decades. Recently, researchers tried seek intrinsic TAM phenotypic functional changes through metabolic connections. Numerous metabolites derived identified that induce cell-cell crosstalk with TAMs. bulk cells, stromal cells produce are involved regulation Meanwhile, some regulate biological functions well. Here, we review recent reports demonstrating between

Language: Английский

Citations

263

Gain Fat—Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis DOI Creative Commons
Dana Ishay-Ronen,

Maren Diepenbruck,

Ravi Kiran Reddy Kalathur

et al.

Cancer Cell, Journal Year: 2019, Volume and Issue: 35(1), P. 17 - 32.e6

Published: Jan. 1, 2019

Language: Английский

Citations

243

Prostate cancer reactivates developmental epigenomic programs during metastatic progression DOI

Mark M. Pomerantz,

Xintao Qiu, Yanyun Zhu

et al.

Nature Genetics, Journal Year: 2020, Volume and Issue: 52(8), P. 790 - 799

Published: July 20, 2020

Language: Английский

Citations

231

Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling DOI
Joseph M. Chan,

Samir Zaidi,

Jillian Love

et al.

Science, Journal Year: 2022, Volume and Issue: 377(6611), P. 1180 - 1191

Published: Aug. 18, 2022

Drug resistance in cancer is often linked to changes tumor cell state or lineage, but the molecular mechanisms driving this plasticity remain unclear. Using murine organoid and genetically engineered mouse models, we investigated causes of lineage prostate its relationship antiandrogen resistance. We found that initiates an epithelial population defined by mixed luminal-basal phenotype it depends on increased Janus kinase (JAK) fibroblast growth factor receptor (FGFR) activity. Organoid cultures from patients with castration-resistant disease harboring mixed-lineage cells reproduce dependency observed mice up-regulating luminal gene expression upon JAK FGFR inhibitor treatment. Single-cell analysis confirms presence JAK/STAT (signal transducer activator transcription) signaling a subset metastatic disease, implications for stratifying clinical trials.

Language: Английский

Citations

208

A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells DOI
Shiyang Shen, Xiao Xu, Shiqi Lin

et al.

Nature Nanotechnology, Journal Year: 2021, Volume and Issue: 16(1), P. 104 - 113

Published: Jan. 1, 2021

Language: Английский

Citations

201